Everyday Health on MSN

Quitting Zepbound Leads to at Least 25 Percent Weight Regain After a Year

Most people who stopped taking their weight loss injections also experienced negative changes in blood pressure, waist size, and other health metrics.

Lilly’s experimental shot cuts body weight by 23% in study

A next-generation obesity shot from Eli Lilly and Co. helped patients lose almost a quarter of their body weight, potentially ...

A better Ozempic? Eli Lilly’s new obesity drug cut weight by 23%, study finds

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...
The New York Sun

Zepbound Maker Eli Lilly Reports Patients Achieved Dramatic Weight Loss in Study of Newest Obesity Drug

Some patients dropped out of the trial early because they had lost so much weight.
Yahoo

Wegovy vs. Zepbound: Study reveals which is better for weight loss

(NewsNation) — A new study has pitted Wegovy and Zepbound head-to-head in their ability to treat obesity. Published in The New England Journal of Medicine on May 11, the study attempted to ...

Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

Weight-loss drug developers line up to tap lucrative market as competition heats up

The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently ...
Healthline

Why Am I Not Losing Weight on Zepbound?

Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug ...